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Introduction
Rasmussen’s encephalitis is a chronic inflammatory disease 
of unknown origin, usually affecting one brain hemisphere, 
described by Rasmussen and co-workers in 1958.[1] Locally, 
this is the first reported case in our 6 years of neurology 
practice at Lagos State University Teaching Hospital. It has 
been reported in adolescents, adults and more in children 
less than 10 years of age.[1,2] It is an uncommon unilateral 
hemispheric disease. Etiologically, there are different 
theories.
A school of thought support an autoimmune pathology.[3] 
Supporting this theory was presence of antibodies said to 
bind to type-3 glutamate receptor (GLUR3).[3] Another 
study documented cytotoxic T cells reacting against nerves 
taken from the affected hemisphere’s brain tissue.[4] Decades 
back, it was postulated to be an infective process.[1] Recently, 
cytomegalovirus and herpes simplex virus 1 viral sequences 
has been detected at autopsy.[5] Trigger factors include viral 
infections, bacterial infections and past history of head 
injury. Clinical presentation is dependent on anatomical 
site and age at presentation. This includes the following: 
Epilepsy, focal or continuous, neurological deficits; aphasia 
(receptive or expressive); and cognitive deficits (memory 
intellectual impairment, neuropsychological deficits 
problems).
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Abstract
Background: Rasmussen’s encephalitis is an uncommon chronic inflammatory disease disorder of unknown etiology.
Objectives: The aim of this report was to create an awareness of Rasmussen’s encephalitis in our clinical practice in 
Africa.
Materials and Methods: We searched online for literature on Rasmussen’s encephalitis with an emphasis on documented 
cases in Africa and in blacks all over the world.
Results: Master F.M., a 14-year-old male, presented with history of recurrent seizures on three occasions. The first 
was after an upper respiratory tract infection, the second was a post-complicated meningo-encephalitis and the third 
episode was associated with receptive aphasia, hemiparesis and intellectual impairment. Neuroimaging studies revealed 
cerebellar atrophy and infarction of territory of the middle cerebral artery. His electroencephalogram showed bi-frontal 
theta activity left>right and poly spikes left>>right, diagnostic of complex partial seizures. In a period of 12 months, his 
gait and speech had improved while his intellectual impairment permitted re-admission into a lower academic class. 
He is presently on phenytion and prednisolone tablets only.
Conclusion: Master F.M. had all the clinical features buttressed with neuroimaging results of a clinically probable 
Rasmussen’s encephalitis. However, an advanced neuroimaging study is needed to detect and quantify hemispherical 
volume loss.
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Stage 1 is the period from the first epileptic seizure until 
the beginning of stage 2. Stage 2 is defined as the acute 
phase of the disease, with a rapid increase in seizure 
frequency (to >10/day) accompanied by the development 
or deterioration of a hemiparesis until the completion of 
neurological deterioration. Stage 3 is defined as a relatively 
stable state, with a permanent hemiparesis and a seizure 
frequency lower than that during stage 2. Neuroimaging 
studies have proven that brain tissue volume loss was 
significantly higher in the affected than in the unaffected 
hemispheres at a rate of 29.9 cm3/year vs. 6.8 cm3/year.[7] 
There is decreased cerebral blood flow and, generally, a 
hypometabolic state of the affected side.[8]
Case Report
Master F.M., a 14-year-old male, presented with a 3-week 
history of recurrent seizures and 1 week history of fever. 
The patient’s medical history has been uneventful until 
March 2006, when he presented to the emergency unit with 
clinical features suggestive of sepsis with meningeal extension. 
He was first reviewed as a consult to the neurology unit, who 
made a diagnosis of meningo-encephalitis.
During the first review, cognitive functions were intact 
and he went back to school and was coping academically. 
He was re-admitted again in January 2008 after a 
3-week history of left upper limb motor seizures, poor 
response to call and vomiting as a case of complicated 
meningo-encephalitis±cerebral abscess. These features 
were recurrent on admission and the neurology unit was 
invited again. Additional features included a low-grade fever 
associated with dry cough and weakness of the left half of the 
body. His genotype was AA. He had an undiagnosed allergic 
rhinitis that comes on twice in a year, which is relieved with 
one or two cough tablets. He had an uneventful minor fall 
before the age of 5 years.
Salient negatives
Blood transfusions, neurosurgery, peri- and post-natal 
events, developmental milestones, traumatic head injury, 
recreational drug use, proven allergies and family history of 
epilepsy. He has a younger brother in a monogamous family. 
His academic performance was satisfactory (form IV) until 
after the second ictus of which patient had to stop school. 
He did not exhibit neuropsychiatric features.
Clinical examination revealed a mildly pale, febrile, 
mildly dehydrated lanky adolescent. He was not icteric 
and his peripheral lymph nodes were not enlarged. He 
was conscious and alert with receptive aphasia. There 
was a decline in intellectual functions, evident by poor 
school reports. He could cooperate with the clinician for 
the Foinstein Minimental Status. There were no signs of 
meningeal irritation. All cranial nerves were intact. He 
walked with a mild hemiplegic gait. He had grade IV left 
spastic hemiparesis. Other systems were essentially normal.
Diagnosis
Focal encephalitis (Rasmussen’s encephalitis)
The following differentials were entertained: Mollaret’s 
meningitis, space occupying lesion (brain abscess, brain 
tumor) and epilepsy.
Results of his cerebrospinal fluid analysis: Xanthochromic, 
gram positive cocci and cell count <5 × 10/mm.3 Glucose 
was 59 mg/dl, protein 100 mg/dl and culture yielded no 
growth in 24 h. Antinuclear antibodies were 20.5 IU/ml. 
The cerebrospinal fluid sample was not sent for tumor 
markers and malignant cell examination.
Negative results were obtained for Venereal Diseases 
Research Laboratory, rheumatoid factor and retroviral I 
and II. Other results of patient’s laboratory investigations, 
obtained at different times whilst on admission [between 
2/082006 – 20/01/2008] revealed the following: his packed 
cell volume ranged from 34% - 38%; white blood cell count 
7,800 – 11000mm3 with a neutrophilic predominance; 
erythrocyte sedimentation rate 15 – 118 mm/hour; platelets 
count 175,000 – 504,000 109/L. His blood film picture 
showed anisocytosis and poikilocytosis whilst parasitology 
revealed few malaria parasites. However electrolytes, urea, 
creatinine and urinalysis were within normal limits
His electroencephalogram showed low amplitude 13 hertz/cycle 
alpha alfa rhythm, moderate β activity, bifrontal theta activity 
left>right and poly spikes left>>right [Figures 1]. The 
computerized tomogram revealed a wedge-shaped hypodense 
non-enhancing lesion in the right parietal lobe, which was 
indicative of infarction. Prominence of ventricles with widening 
of the cerebellar sulci was suggestive of cerebellar atrophy. 
(Patient till date has no cerebellar signs.) The radiologist 
concluded with infarction in the middle cerebral artery territory 
[Figures 2a and 2b].
He was placed on the following drugs: Phenytion, 
prednisolone, omeprazole and intravenous antibiotics. He 
is coping well in primary 2.
His total prednisolone dose is now 30 mg and phenytion 
total dose is 400 mg daily, all in divided doses.
The patient and his parents visit the neurology outpatient 
clinic twice a year. His last review was in September 2009.
Discussion
There was an 18-month interval between the 1st and the 
2nd admission. His gait and speech improved after the 
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1st admission. Seizures abated soon, but progress in 
intellectual impairment was sluggish. He could not perform 
at the secondary school level. He was re-admitted into a 
primary school and demoted into primary class II. Our 
patient’s cognitive decline cannot be explained with the 
differentials entertained (Mollaret’s meningitis, brain 
abscess, brain tumor and epilepsy). ALthough epileptic 
seizures can start at this, they are not accompanied by 
recurrent infections and, when under early control with 
antiepileptic drugs, cannot explain patient’s cognitive 
decline. Our patient’s seizure history is more in keeping with 
the natural history of a Rasmussen’s encephalitis.
Management of Rasmussen’s encephalitis is tailored to 
control epilepsy and modify disease progression with the aid 
of the following: Antiepileptic drugs, immune suppressants, 
immune modulators, plasmapheresis and intravenous 
immunoglobulin.
Our patient manifested with different seizure types 
at different stages. He was actually managed with 
sodium valproate, carbamazepine and phenytion. These 
antiepileptic drugs were used at different times while on 
admission and were not used all together at once. Phenytoin 
was preferred due to its different routes of administration 
and it being a second choice for all manifested seizure 
types. Hemispherectomy might be of benefit to some young 
patients (partial/total).[9] This is usually performed only at 
later stages of the disease, when a patient has developed a 
fixed hemiparesis with loss of fine finger movements. Our 
patient does not qualify for surgical management.
Conclusion
Retrospectively, our patient presented with the natural 
history of a clinically probable Rasmussen’s encephalitis. 
Although we could not perform advanced neuroimaging 
studies, which will confirm and quantify hemispherical 
volume loss, he is presently in MNI stage 3.
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Figure 1: Interictal electroencephalogram of the patient
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Figure 2:	Computed	tomograms	of	the	patient.	(a)	Wedge	shaped	
hypo dense non-enhancing lesion in the right parietal lobe. 
(b)	Prominence	of	ventricles	with	widening	of	the	cerebellar	sulci
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